ENFLONSIA
LIVE

Serial Number

97722844

Owner

Merck Sharp & Dohme LLC

Attorney

Palak Mayani

First Use Date

Aug 18, 2025

Filing Date

Dec 19, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ENFLONSIA Trademark

Serial Number: 97722844

ENFLONSIA is a trademark filed by Merck Sharp & Dohme LLC on December 19, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Merck Sharp & Dohme LLC (4 trademarks)

126 East Lincoln Avenue
Rahway, NJ 07065

Entity Type: 16

Trademark Details

Filing Date

December 19, 2022

Registration Date

Not Registered

First Use Anywhere

August 18, 2025

First Use in Commerce

August 18, 2025

Published for Opposition

October 31, 2023

Goods & Services

Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of RSV; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders

Filing History

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 10, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 10, 2026 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 1, 2026 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Apr 30, 2026 SUPC
SOU EXTENSION 4 GRANTED
Apr 30, 2026 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 27, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Oct 31, 2025 EEXT
SOU EXTENSION 4 FILED
Oct 30, 2025 EXT4
USE AMENDMENT FILED
Oct 29, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 29, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jun 4, 2025 EX3G
SOU EXTENSION 3 FILED
Jun 4, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 4, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 13, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 13, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 13, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 13, 2025 REAP
SOU EXTENSION 2 GRANTED
Nov 21, 2024 EX2G
SOU EXTENSION 2 FILED
Nov 20, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 20, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 10, 2024 EX1G
SOU EXTENSION 1 FILED
Jun 10, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 9, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 26, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 31, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 31, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 11, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2023 CNSA
ASSIGNED TO EXAMINER
Sep 20, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2022 NWOS
NEW APPLICATION ENTERED
Dec 22, 2022 NWAP